Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Incredibly Undervalued Growth Stock to Buy Hand Over Fist in May

TheMotleyFool

0 0

1 Incredibly Undervalued Growth Stock to Buy Hand Over Fist in May: https://g.foolcdn.com/editorial/images/730934/cleanroom.jpg

Growth stocks have performed surprisingly well in 2023. Despite ever-rising interest rates, a possible recession, and a regional banking crisis, the growth-oriented Nasdaq Composite has ticked higher by an impressive 14.8% so far this year.

Which growth stocks ought to continue to march northward in the second quarter of the year and beyond? Innovation juggernaut CRISPR Therapeutics (NASDAQ: CRSP) has crushed the broader markets through the first four months of 2023. This trend seems likely to continue due to its underappreciated pipeline and prospects as a top buyout candidate. Read on to find out more.